Clinical Trial

Intraperitoneal Pressure Measurements Survey in Pediatric Centers

Study acronym: IPP
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 14, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Intraperitoneal pressure (IPP) is an objective measurement used to assess tolerance to fluid volume. IPP has been shown to be strongly correlated with intraperitoneal dialysate volume as well as anthropometric parameters. In observational studies conducted in adults, an IPP greater than 13-14 cmH2O was associated with an increased risk of peritonitis, initiation of hemodialysis, or death. Measuring IPP is therefore a tool to optimize dialysis prescriptions. However, this measurement is not well standardized, and there is limited scientific evidence regarding its impact on patient management. Measuring IPP is a tool to optimize dialysis prescriptions. However, this measurement is not well standardized, and there is limited scientific evidence regarding its impact on patient management. Some centers do not perform any measurements, others perform them monthly, and some only during peritoneal equilibration tests. The hypothesis of this research is to highlight current practices and experiences in measuring intraperitoneal pressures in children undergoing peritoneal dialysis in different European dialysis centers, in order to improve practices regarding PIP prescription.
Trial Details
NCT Number NCT07339709
Lead Sponsor University Hospital, Strasbourg, France
Conditions Pediatric Renal Failure
Enrollment 100 participants
Start Date 2025-07-16
Primary Completion 2026-07 (estimated)
Study Completion 2026-07-16 (estimated)
Updated on ClinicalTrials.gov 2026-01-14